Genitourinary Cancer section

Genitourinary Cancer News & Features

Atezolizumab Has Some Benefits in Urothelial Carcinoma, But OS Not Improved

Atezolizumab Has Some Benefits in Urothelial Carcinoma, But OS Not Improved

In the IMvigor 311 trial, researchers sought to determine if atezolizumab improves overall survival for patients with metastatic urothelial carcinoma vs physicians' choice of 3 IV regimens.

Cardiopulmonary Fitness Leads to Better Outcomes in Bladder Cancer Surgery

Cardiopulmonary Fitness Leads to Better Outcomes in Bladder Cancer Surgery

A feasibility study involving 60 patients with bladder cancer sought to determine if preoperative vigorous cardiovascular activity would improve postsurgical outcomes.

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.

New Tool Identifies Mortality Risk After Bladder Cancer Surgery

New Tool Identifies Mortality Risk After Bladder Cancer Surgery

Tool incorporates the relative contribution of tumor stage and lymph node involvement.

First-line Pembrolizumab May Be Efficacious for Cisplatin-ineligible Urothelial Cancer

First-line Pembrolizumab May Be Efficacious for Cisplatin-ineligible Urothelial Cancer

Approximately 50% of patients with advanced urothelial carcinoma are unable to receive standard first-line cisplatin-based chemotherapy, indicating a need for additional treatment options.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs